1,5-Anhydro-D-fructose (1,5-AF) is a monosaccharide that shares a structural similarity to glucose. 1,5-AF is found in fungi, algae, Escherichia coli and rat liver and is produced by the degradation of starch and glycogen, which is catalyzed by the enzyme α-1,4-glucan lyase. However, the physiological role of 1,5-AF in mammalian tissues is not well understood. Here, we investigated the anti-obesity potential of 1,5-AF on adipogenesis in 3T3-L1 adipocytes. 1,5-AF caused a significant decrease in GPDH activity in 3T3-L1 preadipocytes and mature adipocytes without eliciting cytotoxicity, and inhibited cellular lipid accumulation through down-regulation of transcription factors such as PPARγ and C/EBPα1,5-AF also induced dose-dependent phosphorylation of AMPactivated protein kinase (AMPK), a cellular energy sensor. However, the total AMPK protein content remained unchanged. Furthermore, 1,5-AF increased the levels of reactive oxygen species, an important upstream signal for AMPK activation in 3T3-L1 adipocytes. Our results show that 1,5-AF exerts anti-obesity action in vitro and suggest that 1,5-AF is potentially a novel preventative agent for obesity and other metabolic diseases.
Obesity is a significant risk factor for various metabolic diseases, such as hypertension, cardiovascular disease, and type 2 diabetes [1] . Therefore, obesity is a major public health concern in many countries. Obesity is characterized by excessive fat deposition, which is associated with morphological and functional changes in adipocytes [2] . Adipocytes are the primary sites for energy storage, and they accumulate triglycerides under certain circumstances, such as nutritional excess (energy imbalance), nutrient deficiencies, excessive stress, and genetic predispositions. Exposure of adipocytes to differentiation-inducing agents initiates a wellcharacterized cascade of gene expression events that lead to the mature adipocyte phenotype. During adipocyte differentiation, transcription factors, such as peroxisome proliferator-activated receptor (PPARγ and CCAA/T enhancer-binding proteins (C/EBPs) are involved in the sequential expression of adipocytespecific proteins [3] . The differentiation cascade begins with expression of C/EBPβ within hours of treatment with inducing agents. C/EBPβ promotes the expression of PPARγ and C/EBPα [4] . Both of these factors are necessary to promote the terminal or mature adipocyte phenotype [5] .
AMP-activated protein kinase (AMPK) monitors the intracellular energy status and regulates the uptake and metabolism of glucose and fatty acids, as well as the synthesis and oxidation of fatty acids, cholesterol, glycogen and protein to meet energy demands [6] [7] . Recent studies suggest that AMPK is involved in the regulation of glucose and lipid metabolism and acts as a regulator of adipocyte differentiation. Dogan et al. examined the effect of the AMPK activator, AICAR, on F442a adipocytes and found that activation of AMPK induced dose-dependent apoptotic cell death and downregulation of key adipogenic genes, such as PPARγ and C/EBPα [8] . Furthermore, Gili et al. reported that AICAR blocked adipogenic conversion in 3T3-L1 cells [9] . 1,5-Anhydro-D-fructose (1,5-AF) is a recently identified monosaccharide that is produced by the degradation of starch and glycogen, which is catalyzed by the enzyme α-1,4-glucan lyase [10] . 1,5-AF was first discovered in fungi in 1996 [11, 12] . It was also observed that a subcellular membranous fraction from aoil bacterium (Pseudmonas sp.) catalyzed the oxidation of 1,5anhydro-D-glucitol to 1,5-AF [13] . Since its initial discovery, 1,5-AF has been detected in a variety of organisms, including Escherichia coli [14] and rat liver tissue [15] . 1,5-AF likely acts as an anti-oxidant that scavenges reactive oxygen species (ROS) induced by phorbol myristate acetate in THP-1 cells and by coppermediated LDL oxidation [16, 17] . Ahren et al. also reported that 1,5-AF increased glucose tolerance in mice by increasing insulin secretion through increased plasma levels of glucagon-like peptide-1 [18] . Additionally, Mei et al. have shown that there was no difference in body weight compared with mice that received placebo on either a normal or high fat diet [19] . The physiological role of 1,5-AF in mammalian tissues is not well understood. In this study, we investigated the anti-obesity potential of 1,5-AF on adipogenesis in 3T3-L1 adipocytes.
The viability of 3T3-L1 preadipocytes after treatment with 200, 400 or 800 μg/mL of 1,5-AF was determined by the neutral red assay. Cell viability at 24 h was 119.9 ± 2.0%, 121.4 ± 2.0% and 120.3 ± 2.6% of controls for cells treated with 200 μg/mL, 400 μg/mL and 800 μg/mL 1,5-AF, respectively, which shows that these concentrations of 1,5-AF are not cytotoxic to 3T3-L1 preadipocytes.
The effect of 1,5-AF on intracellular lipid accumulation was examined by Oil Red O staining. On the 8th day after initiation of differentiation, mature 3T3-L1 adipocytes accumulated many Oil Red O stained materials (OROSAM), as indicated by the appearance of large intracellular droplets. Most control cells accumulated lipid droplets ( Figure 1A) ; however, cells treated with 1,5-AF accumulated smaller lipid droplets than control cells, which suggests that 1,5-AF inhibits the accumulation of intracellular triglyceride in 3T3-L1 preadipocytes. To ascertain the mechanism of 1,5-AF-mediated inhibition of intracellular triglyceride accumulation in 3T3-L1 preadipocytes, we examined the effect of 1,5-AF on the activity of GPDH, a key enzyme of triglyceride synthesis. Cultured 3T3-L1 preadipocytes were exposed to 1,5-AF and allowed to differentiate by incubation in differentiation medium. As shown in Figure 1B , treatment of 3T3-L1 preadipocytes with 1,5-AF significantly inhibited GPDH activity in a dose-dependent manner. 1,5-AF inhibits intracellular triglyceride accumulation and GPDH activity without cytotoxicity in 3T3-L1 preadipocytes. Therefore, we examined the effect of 1,5-AF on the expression of adipogenesis factors in 3T3-L1 preadipocytes. To determine whether the reduced lipid accumulation and GPDH activity caused by 1,5-AF alter the differentiation program in cells, the expression levels of some adipogenic proteins were examined by Western blot analysis. As shown in Figures 2A, 2B and 2C, 1,5-AF treatment reduced the protein levels of some major adipogenic transcription factors, including PPARγ, C/EBPα and C/EBPβ. 1,5-AF reduced expression of these factors in a dose-dependent manner.
The viability of fully differentiated 3T3-L1 adipocytes treated with 400 or 800 μg/mL 1,5-AF was examined by neutral red assay. Cell viability at 24 h was 105.7 ± 2.1% and 107.3 ± 2.6% of controls for 400 μg/mL-treated cells and 0.8 mg/mL-treated cells, respectively, which suggests that these concentrations of 1,5-AF are not cytotoxic to mature 3T3-L1 adipocytes. As shown in Figures 3A and 3B, control cells accumulated lipid droplets. However, mature adipocytes treated with 1,5-AF accumulated smaller lipid droplets than control cells, indicating that 1,5-AF also inhibits the accumulation of intracellular triglyceride in mature 3T3-L1 adipocytes. Figures 4A and 4B , 1,5-AF treatment reduced the protein levels of major adipogenic transcription factors, including PPARγ, and C/EBPα in mature adipocytes.
As shown in
ROS are involved in the inhibition of fat accumulation by natural compounds and are required for activation of the AMPK signaling pathway [20] . Therefore, we evaluated whether ROS release and activation of AMPK is involved in the inhibition of accumulation of intracellular triglyceride in 1,5-AF-treated 3T3-L1 cells. As shown in Figure 5 , ROS levels were rapidly increased by 1,5-AF treatment. The activation/phosphorylation of AMPK was significantly increased by 1,5-AF treatment ( Figure 5B ), whereas the total AMPK protein content remained unchanged ( Figure 5C ). 1,5-AF is a monosaccharide that shares a structural similarity to glucose. In the present study, we investigated the anti-obesity effects of 1,5-AF and found that 1,5-AF efficiently blocked adipogenesis in 3T3-L1 preadipocytes and mature adipocytes. It was once believed that the number of adipocytes remained constant over one's lifetime. However, in the last decade, researchers have acknowledged that adipocytes can be both gained and lost and that the metabolic consequences of obesity depend on hyperplasia or hypertrophy of adipocytes [21] .
Several recent reports suggest that some saccharides prevent lipid accumulation in vivo. Arai et al. have shown that the intake of trehalose, a nonreducing disaccharide composed of 2 D-glucose residues, suppresses adipocyte hypertrophy and mitigates insulin resistance in high fat diet-induced obese mice. These effects were not observed with glucose, maltose, high-fructose corn syrup and fructose. Mechanistic analysis suggests that trehalose exhibits its suppressive effect by decreasing insulin secretion [22] . Hossain et al. reported that a rare sugar, D-psicose, a C-3 epimer of D-fructose, improved insulin sensitivity and glucose tolerance in the type 2 diabetes model, Otsuka Long-Evans Tokushima Fatty (OLETF) rats. An oral glucose tolerance test revealed reduced blood glucose and insulin levels, suggesting an improvement in insulin resistance in OLETF rats. They also observed that D-psicose significantly reduced lipid accumulation in the liver [23] . These in vivo observations suggested that the saccharides prevented lipid accumulation by decreasing insulin secretion. However, it is not known whether saccharides have a direct effect on adipocytes. Therefore, in this study, we examined the effect of 1,5-AF on cultured 3T3-L1 adipocytes.
To the best of our knowledge, the results of the present study demonstrate, for the first time, that a type of saccharide, 1,5-AF, causes a significant decrease in the activity of GPDH in 3T3-L1 adipocytes without eliciting cytotoxicity. In addition, 1,5-AF inhibits cellular lipid accumulation through down-regulation of transcription factors such as PPARγ and C/EBPα and up-regulation of AMPK. The nuclear receptor PPARγ and members of the C/EBPα complex synergistically activate downstream promoters of adipocyte-specific genes, such as acetyl-CoA carboxylase, acyl-CoA synthase and GPDH. In adipocytes, the expression of cytosolic GPDH is enhanced by high levels of PPARγ [24] .
An involvement of AMPK in adipogenesis, the process by which adipose tissue is formed in obesity, has been previously proposed [25] . Studies by Winder et al. provided the first evidence that AMPK activation may diminish adiposity by demonstrating a sharp reduction in epidermal and retroperitoneal fat pads in rats after treatment with the AMPK activator, AICAR [26] . Our present study suggests that 1,5-AF activated the AMPK signaling pathway and exerted an anti-obesity effect. It has also been reported that berberine inhibits adipocyte differentiation by modulating the AMPK and PPARγ pathways [27] . Genistein also inhibits adipocyte differentiation via AMPK activation [28] . Huang et al. have also shown that preadipocyte 3T3-L1 cells were not able to develop into mature adipocytes in the presence of cinnamaldehyde, one of the active components of cinnamon, and that this effect was reversed when the cells were pre-treated with compound C, an AMPK inhibitor [29] . Furthermore, Gao et al. examined the association of AMPK with C/EBPα and PPARγ (key transcription factors for adipogenesis and lipogenesis) under compound C treatment and found that the compound significantly reduced C/EBPα and PPARγ mRNA levels, which are normally increased by differentiation inducers in 3T3-L1 cells. This reduction in mRNA levels subsequently led to attenuated transcription of late adipogenic marker genes such as FAS and AP2 [30] .
Hwang et al. observed that ROS are important upstream signals for AMPK activation during the genistein-, epigallocatechin gallateand capsaicin-induced blockade of adipocyte differentiation [28] . These phytochemicals significantly activated AMPK and effectively inhibited adipocyte differentiation via PPARγ inhibition. In the present study, we found that 1,5-AF treatment caused ROS formation in 3T3-L1 cells. However, Yamaji et al. reported that 1,5-AF likely acts as an anti-oxidant that scavenges ROS induced by phorbol myristate acetate treatment of THP-1 cells [16] . It has been shown that endogenous and dietary antioxidants can either be potent antioxidants or pro-oxidants depending on the treatment conditions. Chobot and Hadacek have shown that myricetin exhibited antioxidant properties in the presence of ascorbic acid and iron, but its pro-oxidant activities prevailed in the presence of iron and its chelator [31] . Furthermore, Yin et al. demonstrated that endogenous and dietary antioxidants can exhibit pro-oxidative activity in the presence of copper [32] . These results suggest that the anti-obesity effects of 1,5-AF are associated with ROS formation and activation of the AMPK signaling pathway in 3T3-L1 adipocytes.
In conclusion, we report that 1,5-AF exerts an anti-obesity effect. 1,5-AF inhibits the expression of key transcription factors and genes responsible for adipocyte differentiation. In addition, we have shown that activation of AMPK by 1,5-AF in adipocytes plays a critical role in the regulation of 1,5-AF-induced inhibition of adipocyte differentiation. Although understanding the precise mechanism of inhibition requires further study, 1,5-AF has novel preventive potential for obesity and other metabolic diseases. Cell culture and adipocyte differentiation: Mouse embryo 3T3-L1 cells were obtained from the Human Science Research Resource Bank (HSRRB, Osaka, Japan). 3T3-L1 preadipocytes were incubated in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% FBS at 37°C in a humidified 5% CO 2 incubator. Differentiation into adipocytes was induced by incubation of 10 5 cells in MDI differentiation medium (DMEM containing 10% FBS, 0.5 mM IBMX, 0.25 μM DEX and 0.2 μM insulin) for 2 days. The cells were then incubated for an additional 2 days in DMEM containing 10% FBS and 0.2 μM insulin. The medium was then replaced with normal culture medium and changed every 2 days. To examine the effects of 1,5-AF on the differentiation of preadipocytes into adipocytes, cells were cultured in MDI differentiation medium in the presence of various concentrations of 1,5-AF. The cells were harvested at 1, 2 or 8 days after initiation of differentiation. To examine the effects of 1,5-AF on mature adipocytes, fully differentiated 3T3-L1 cells were treated with normal culture medium containing various concentrations of 1,5-AF for 3 days.
Neutral red assay:
Cell viability was determined with the neutral red uptake assay, which is based on the lysosomal uptake of neutral red [33] . Following specified incubations with test agents, neutral red solution (0.25 mg/mL) was added to the cell cultures at a final concentration of 50 μg/mL neutral red. After incubation at 37°C for 2 h, cells were rinsed twice with a mixture of 1% (v/v) formaldehyde, 1% (v/v) calcium chloride, and 98% (v/v) distilled water. Subsequently, 1 mL of destaining buffer consisting of 1% (v/v) acetic acid, 50% (v/v) ethanol, and 49% (v/v) distilled water was added to the cells and incubated for 30 min. Lysosomal uptake of neutral red was quantified spectrophotometrically at 540 nm [34, 35] . Viability was expressed as (A540-treated cells/A540 of appropriate control) × 100%, after correction for background absorbance.
Anti-adipogenic activity of 1,5-AF Natural Product Communications Vol. 7 (11) 2012 1505 Oil Red O staining: Intercellular lipid accumulation was measured by Oil Red O staining. The Oil Red O working solution was prepared as previously described [35, 36] . Undifferentiated 3T3-L1 preadipocytes were induced to differentiate into adipocytes as described above. Cells were incubated with 1,5-AF during the differentiation period and then washed twice with phosphate buffered saline (PBS) and fixed for 30 s with 70% ethanol. Next, the cultures were incubated for 2 h with a saturated solution of Oil Red O in 99% isopropyl alcohol, rinsed for 3 s in 50% ethanol, and washed two times with deionized water. Glycerol 2-phosphate dehydrogenase (GPDH) activity: 3T3-L1 adipocytes were harvested 8 days after initiation of differentiation with 1,5-AF. Cells were carefully washed twice with ice-cold PBS and collected with a scraper into 300 μL of 100 mM triethanolamine/HCl buffer (pH 7.5) containing 2.5 mM EDTA. Harvested cells were sonicated in 25 x 10 s ultrasonic bursts in a DU-250 Bioruptor with a maximum output power of 250 W (Tosho Denki Co. Ltd., Japan). Between sonications, samples were chilled on ice. After centrifugation at 13,000 × g for 5 min at 4°C, the supernatants were assayed for GPDH activity according to the Wise and Green method [37] . GPDH activity was measured under zeroorder kinetics and optimal substrate and cofactor conditions at 25°C for 180 s in a spectrophotometer (Beckman Coulter, DU 530). The standard reaction mixture contained 100 mM triethanolamine/HCl buffer (pH 7.5), 2.5 mM EDTA, 0.1 mM 2-mercaptoethanol, and 0.12 mM NADH. The reaction was initiated by the addition of 0.2 mM dihydroxyacetone phosphate, and the rate of NADH oxidation was measured as the change in absorbance at 340 nm for 60 s. Enzyme activity (%) was expressed as a ratio of the experimental condition relative to the control (which was set at 100% activity).
Western blot analysis:
Cells were harvested 48 h after initiation of differentiation or 5 days after differentiation with 1,5-AF, washed twice in PBS and lysed by incubation in lysis buffer [150 mM NaCl, 50 mM Tris (pH 7.2), 1 mM EDTA, 0.5% sodium deoxycholate, 1% Nonidet P-40, 1 mM sodium vanadate, 1 mM NaF, 20 μg/mL aprotinin, 50 μg/mL leupeptin, 10 μg/mL pepstatin A and 100 μg/mL phenylmethylsulfonyl fluoride] for 30 min. Finally, the solution was centrifuged at 2,000 × g for 20 min at 4°C. The protein concentration of the supernatant was determined by the Bradford method. Equal amounts of protein were resolved on a 10% SDS-PAGE gel and transferred to a 0.45 μm PVDF membrane (Hybond, Amersham Pharmacia Biotech). After blotting overnight in 0.1% Tween-20 and 5% non-fat dry milk (in PBS), blots were incubated with anti-PPARγ, anti-C/EBPα anti-AMPK or antiphosphorylated AMPK antibodies for 1 h at room temperature. After washing, the membrane was incubated with a 1:500 dilution of either biotinylated mouse IgG or rabbit IgG for 1 h at room temperature. The membrane was washed several times and incubated with a 1:500 dilution of horseradish peroxidase-coupled streptavidin for 1 h at room temperature. After several washing steps, the color reaction was developed with DAB. Densitometry analysis of the protein bands was performed with Scion Image software.
Intracellular ROS formation:
A relatively specific probe for hydrogen peroxide, 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA), was used to analyze the formation of intracellular ROS. Cells were incubated with 2.4 mM DCFH-DA (5 μL) during the final 30 min of treatment. Cells were washed twice with PBS before resuspension in Hank's solution. Fluorescence intensity was detected with an SFX100 Bio Imaging Navigator (Olympus, Japan).
Statistical analysis:
Data are expressed as the mean ± standard deviation. The significance of differences in assay values was evaluated by ANOVA followed by Tukey multiple tests. A value of p < 0.05 was used to indicate statistical significance.
